Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million

Oct 07, 2019•about 6 years ago

Amount Raised

$375,000

Round Type

seed

New YorkBiotechnology

Company Information

Company

EpiVax Oncology, Inc.

Location

180 Varick Street

New York, New York, United States

About

EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. EpiVax Oncology’s therapeutic vaccines are customized and specifically designed for each patient’s tumors, leveraging advances in next generation immunology.

Related People

5 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information